San Francisco, CA, United States of America

Carlos Mc De Noronha

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos Mc De Noronha. Retrieved from https://idiyas.com/inventor/carlos-mc-de-noronha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Carlos Mc De Noronha

Introduction

Carlos Mc De Noronha is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of molecular delivery systems. His innovative work focuses on enhancing the effectiveness of therapeutic molecules through advanced delivery methods.

Latest Patents

Carlos holds a patent for "Compositions and methods for delivery of a molecule into a cell." This invention provides a composition that includes a Vpr polypeptide conjugated to a therapeutic molecule. The Vpr can be synthetic, and the therapeutic molecule may include polypeptides, polynucleotides, or toxins. The patent also outlines methods for delivering molecules into cells, modulating transgene expression, killing target cell populations, increasing sensitivity to radiation therapy, and inhibiting cell proliferation.

Career Highlights

Carlos is affiliated with the University of California, where he continues to advance his research and development efforts. His work has the potential to impact various therapeutic applications significantly.

Collaborations

Carlos has collaborated with notable colleagues, including Michael P Sherman and Warner C Greene. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Carlos Mc De Noronha's contributions to molecular delivery systems exemplify the intersection of innovation and therapeutic advancement. His patent and ongoing research hold promise for future medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…